Abstract
We look at two mechanisms in Germany that concern patenting and licensing of publicly funded science. The first is the function of Ipal GmbH which undertakes patenting and licensing of technologies originating in the universities in Berlin and the second is that of the Max Planck Innovations (MPI), nodal centre for technology transfer of the Max Planck Society (Max Planck Gesellschaft (MPG)). This article presents case studies of patenting and licensing practices at the Humboldt University of Berlin (against the Ipal GmbH model) and those at MPG (the MPI model). The analysis is structured around core issues pertaining to IPR and academic research, science-industry interface and technology transfer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
